AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹259 Cr | ₹131 Cr | ₹85 Cr | ₹73 Cr | - |
What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹259 Cr |
| Mar2024 | ₹131 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | - |
How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹259 Cr | 98.54 | |
| Mar2024 | ₹131 Cr | 53.89 | |
| Mar2023 | ₹85 Cr | 16.71 | |
| Mar2022 | ₹73 Cr | 0 | |
| Mar2021 | - | - | |
Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,249.2 Cr | 6.1% | 1.1% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 6.1% |
1.1% |
-15.5% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses